Missing/wrong data?
Log in to edit
Clinical efficacy of the selective endothelin A receptor antagonist, atrasentan, in patients with diabetes and chronic kidney disease (CKD)
scientific article published on February 2, 2012
Author/s
author: Mark E Molitch
Work details
Publication date
February 2, 2012
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.